Company profile
Nanjing Letop Biotechnology Co., Ltd. is a scientific and technological innovative enterprise integrating research and development, production and sales of functional raw materials. The company has a biological fermentation platform and the core technology of enzyme catalysis. Relying on the strong research and development and technical background of Sino-US pharmaceutical companies, the company focuses on providing consumers with high-quality and clinically valuable raw materials with functional value with the pharmaceutical concept. At present, the company sells more than 20 products, including:
· Functional food raw materials: small molecule chondroitin sulfate LetopCS®, drilonetin, GABA, cartilage extract, NMN, ergothioneine, etc.;
·· Medical beauty raw materials: nano-sodium hyaluronate nmHA® and various customized molecular weight sodium hyaluronate, acetylated sodium hyaluronate, cationic sodium hyaluronate, PDRN, ergothionein, ecdoine, recombinant Type III humanized collagen, GABA, etc.;
· Pharmaceutical intermediates and apis: Degu insulin side chain, progesterone, retinoic acid, epinephrine, VK1, etc.
In order to expand the production scale and market investment of the enterprise, the two new production bases of "Letop-Lianyungang Chengong Pharmaceutical Co., LTD." and "Letop-Nanjing Mingyang Biotechnology Co., LTD." will be built and put into use soon. "Letop - Lianyungang Chengong Pharmaceutical Co., LTD." Base project with a total investment of 500 million yuan, covers an area of 53 mu of land, with an annual output of hormone biological raw materials (5 tons), biological fermentation raw materials (180 kg) and supporting preparations (1 billion hormone tablets, capsules, content tablets/capsules, 50 million hormone injections). The output value after all reached no less than 200 million yuan. "Letop - Nanjing Mingyang Biotechnology Co., LTD." base project with a total investment of 250 million yuan, covering a total area of 26,000 square meters, the construction of enzyme catalysis, purification, drying, mixing tablet and other processes of 5 production lines, annual output of 10 tons of hyaluronic acid, 10 tons of chondroitin sulfate, 20 tons of aminobutyric acid, 0.6 tons of raw materials and 40 million solid tablets project.
Adhering to the mission of "Let users use safe and effective products", the company always regards scientific and technological innovation as the source of enterprise development, and provides customers with more valuable products and technical services!
Lianyungang Base
|
|
Business liaison：400-828-8379
About Us Hot issues Cooperation promotion
Privacy policy User guide Links